Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms.

ABSTRACT Clonal hematopoiesis (CH) confers a high risk of aging-related diseases and hematologic malignancy. There are still significant knowledge gaps in identifying high-risk patients with CH and managing such patients. In this review, we focus on 3 areas: (1) the natural history of CH; (2) the risks of progression of CH, including CH of indeterminate potential, clonal cytopenia of undetermined significance, and therapy-related CH, to myeloid malignancy; and (3) the challenges and unmet needs of CH management and research.

[1]  A. Zeidan,et al.  CHIPing away the progression potential of CHIP: A new reality in the making. , 2022, Blood reviews.

[2]  Y. Natkunam,et al.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms , 2022, Leukemia.

[3]  A. Diepstra,et al.  Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals , 2022, Blood advances.

[4]  C. Flowers,et al.  Clonal hematopoiesis is associated with increased risk of severe neurotoxicity in axicabtagene ciloleucel therapy of large B-cell lymphoma. , 2022, Blood cancer discovery.

[5]  Andrew T Nguyen,et al.  Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms , 2022, Blood.

[6]  C. Thiede,et al.  Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment , 2022, Blood advances.

[7]  V. Iyer,et al.  Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis , 2022, Nature Genetics.

[8]  Emily F. Calderbank,et al.  Clonal dynamics of haematopoiesis across the human lifespan , 2021, Nature.

[9]  P. Campbell,et al.  The longitudinal dynamics and natural history of clonal haematopoiesis , 2021, Nature.

[10]  Ansuman T. Satpathy,et al.  Clonal hematopoiesis is associated with protection from Alzheimer's disease , 2021, medRxiv.

[11]  Andrew D. Johnson,et al.  Clonal Hematopoiesis Is Associated With Higher Risk of Stroke , 2021, Stroke.

[12]  David M. Evans,et al.  Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis , 2021, The Journal of experimental medicine.

[13]  B. Ebert,et al.  Distinction of lymphoid and myeloid clonal hematopoiesis , 2021, Nature Medicine.

[14]  A. Tinker,et al.  Preexisting TP53-Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients With High-grade Ovarian Cancer Treated With Rucaparib. , 2021, JAMA oncology.

[15]  Tyler J Dougan,et al.  Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation , 2021, medRxiv.

[16]  Sina A. Gharib,et al.  Association of clonal hematopoiesis with chronic obstructive pulmonary disease , 2021, Blood.

[17]  W. Tapper,et al.  Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease , 2021, Leukemia.

[18]  D. Neuberg,et al.  Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy. , 2021, Blood advances.

[19]  M. Cazzola,et al.  Relationship between clone metrics and clinical outcome in clonal cytopenia. , 2021, Blood.

[20]  G. Garcia-Manero,et al.  Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation , 2021, Leukemia.

[21]  Y. Kamatani,et al.  Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis , 2021, Nature Medicine.

[22]  L. Jorde,et al.  Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers. , 2021, Blood cancer discovery.

[23]  R. Fonseca,et al.  Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy , 2021, American journal of hematology.

[24]  Stuart M. Gardos,et al.  Cancer therapy shapes the fitness landscape of clonal hematopoiesis , 2020, Nature Genetics.

[25]  D. Steensma,et al.  What To Tell Your Patient With Clonal Hematopoiesis And Why: Insights From Two Specialized Clinics. , 2020, Blood.

[26]  S. Jaiswal.  Clonal hematopoiesis and non-hematologic disorders. , 2020, Blood.

[27]  G. Getz,et al.  Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant , 2020, Nature Communications.

[28]  M. M. van der Klauw,et al.  Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals. , 2020, Blood.

[29]  T. Druley,et al.  The evolutionary dynamics and fitness landscape of clonal hematopoiesis , 2020, Science.

[30]  J. W. Hansen,et al.  Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study , 2020, Leukemia.

[31]  M. Berger,et al.  The Clinical Management of Clonal Hematopoiesis: Creation of a Clonal Hematopoiesis Clinic. , 2020, Hematology/oncology clinics of North America.

[32]  B. Ebert,et al.  CHIP, CCUS, and Other Acronyms: Definition, Implications, and Impact on Practice. , 2019, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[33]  B. Brüne,et al.  Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous Transplantation. , 2019, Cell reports.

[34]  T. Druley,et al.  Clonal hematopoiesis and risk of acute myeloid leukemia , 2019, Haematologica.

[35]  P. Evans,et al.  The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis. , 2019, Blood.

[36]  L. Bullinger,et al.  Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  E. Papaemmanuil,et al.  Managing Clonal Hematopoiesis in Patients With Solid Tumors. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  L. Bullinger,et al.  Clonal hematopoiesis in patients with ANCA-associated vasculitis. , 2019, Haematologica.

[39]  Alexey Zaikin,et al.  Inflammaging 2018: An update and a model. , 2018, Seminars in immunology.

[40]  S. Mustjoki,et al.  Clonal hematopoiesis in patients with rheumatoid arthritis , 2018, Blood Cancer Journal.

[41]  G. Mufti,et al.  Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation , 2018, Leukemia.

[42]  Stanley W. K. Ng,et al.  Prediction of acute myeloid leukaemia risk in healthy individuals , 2018, Nature.

[43]  D. Steensma,et al.  New Insights from Studies of Clonal Hematopoiesis , 2018, Clinical Cancer Research.

[44]  Steven J. M. Jones,et al.  Comprehensive Characterization of Cancer Driver Genes and Mutations , 2018, Cell.

[45]  T. Haferlach,et al.  Molecular patterns in cytopenia patients with or without evidence of myeloid neoplasm—a comparison of 756 cases , 2018, Leukemia.

[46]  B. Dörken,et al.  Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis , 2018, Leukemia.

[47]  Christopher A. Miller,et al.  Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential , 2018, Nature Communications.

[48]  J. Cerhan,et al.  Long‐Term Follow‐up of Monoclonal Gammopathy of Undetermined Significance , 2018, The New England journal of medicine.

[49]  M. Ladanyi,et al.  Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. , 2017, Cell stem cell.

[50]  M. Dubé,et al.  DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions. , 2017, Blood.

[51]  Kari Stefansson,et al.  Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. , 2017, Blood.

[52]  Christian Gilissen,et al.  Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life. , 2017, American journal of human genetics.

[53]  M. Cazzola,et al.  Clinical significance of somatic mutation in unexplained blood cytopenia. , 2017, Blood.

[54]  S. Gabriel,et al.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.

[55]  A. LaCasce,et al.  Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  Erika J. Thompson,et al.  Pre-leukemic clonal hematopoiesis and the risk of therapy-related myeloid neoplasms: a case-control study , 2016, The Lancet. Oncology.

[57]  Christopher A. Miller,et al.  Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy , 2016, Leukemia.

[58]  H. McLeod,et al.  Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study. , 2017, The Lancet. Oncology.

[59]  T. Druley,et al.  Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults , 2016, Nature Communications.

[60]  S. Barrans,et al.  Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression. , 2015, Blood.

[61]  J. Witte,et al.  MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance. , 2015, Blood.

[62]  B. Ebert,et al.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.

[63]  E. Zeggini,et al.  Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis , 2015, Cell reports.

[64]  T. Ley,et al.  Quantifying ultra-rare pre-leukemic clones via targeted error-corrected sequencing , 2015, Leukemia.

[65]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[66]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[67]  Joshua F. McMichael,et al.  Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.

[68]  C. Franceschi,et al.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[69]  William Wheeler,et al.  Detectable clonal mosaicism and its relationship to aging and cancer , 2012, Nature Genetics.

[70]  Neil E Caporaso,et al.  B-cell clones as early markers for chronic lymphocytic leukemia. , 2009, The New England journal of medicine.

[71]  I. Weissman,et al.  Stems Cells and the Pathways to Aging and Cancer , 2008, Cell.